Importer of Controlled Substances Registration, 55639 [2017-25284]

Download as PDF 55639 Federal Register / Vol. 82, No. 224 / Wednesday, November 22, 2017 / Notices While Congress also amended section ‘‘824(a) to add to the current bases for denial, revocation, or suspension of registration a finding that registration would be inconsistent with the public interest on the grounds specified in [section] 823, which will include consideration of the new factors added by’’ the amendment, id. at 266–67, Congress did not otherwise alter the text of section 824(a), which makes clear that the various paragraphs of this provision are findings, each of which provides an independent and adequate ground to support agency action against a registration, and not discretionary factors to be considered by the Agency. Indeed, Respondent points to nothing in the language of section 824 or the CSA’s legislative history to support his position, which would fundamentally alter the scope of the Agency’s authority under section 824. I therefore reject Respondent’s contentions. Based on the ALJ’s finding that Respondent is not currently authorized to dispense controlled substances in Mississippi, the State in which he holds the DEA registration at issue in this proceeding, I will adopt the ALJ’s recommended order that I revoke his registration. DEPARTMENT OF JUSTICE Order ACTION: Pursuant to the authority vested in me by 21 U.S.C. 824(a), as well as 28 CFR 0.100(b), I order that DEA Certificate of Registration No. AF2451261 issued to Arnold E. Feldman, M.D., be, and it hereby is, revoked. This Order is effective immediately.9 SUMMARY: Dated: November 13, 2017. Robert W. Patterson, Acting Administrator. [FR Doc. 2017–25287 Filed 11–21–17; 8:45 am] BILLING CODE 4410–09–P Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Registration Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration as importers of various classes of schedule I or II controlled substances. The companies listed below applied to be registered as importers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices. SUPPLEMENTARY INFORMATION: Company FR Docket asabaliauskas on DSKBBXCHB2PROD with NOTICES Almac Clinical Services Incorp (ACSI) ........................................................................................................ Stepan Company ......................................................................................................................................... Fresenius Kabi USA, LLC ........................................................................................................................... Cambrex Charles City ................................................................................................................................. Spex Certiprep Group, LLC ......................................................................................................................... Akorn, Inc .................................................................................................................................................... Fisher Clinical Services, Inc ........................................................................................................................ Siegfried USA, LLC ..................................................................................................................................... Mylan Pharmaceuticals, Inc ........................................................................................................................ KVK-Tech, Inc ............................................................................................................................................. Cerilliant Corporation ................................................................................................................................... Unither Manufacturing LLC ......................................................................................................................... Mylan Pharmaceuticals, Inc ........................................................................................................................ Catalent Centers, LLC ................................................................................................................................. Specgx LLC ................................................................................................................................................. Sharp Clinical Services, Inc ........................................................................................................................ Cody Laboratories, Inc ................................................................................................................................ Bellwyck Clinical Services ........................................................................................................................... The Drug Enforcement Administration (DEA) has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company’s maintenance of effective controls against diversion by inspecting and testing each company’s physical 9 While the Mississippi Board Order was based on the Louisiana Board’s Order, as noted in the former Acting Administrator’s Decision and Order which revoked Respondent’s Louisiana registration, the Louisiana Board found proved the sixth charge of the Administrative Complaint in that proceeding, in VerDate Sep<11>2014 18:57 Nov 21, 2017 Jkt 244001 Notice of registration. security systems, verifying each company’s compliance with state and local laws, and reviewing each company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I or II controlled substances to the above listed persons. 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 FR FR FR FR FR FR FR FR FR FR FR FR FR FR FR FR FR FR 37114 41054 41053 41055 42120 42117 42121 42117 42120 42119 43404 43571 43572 43569 43571 43572 45612 45613 Published August 8, 2017. August 29, 2017. August 29, 2017. August 29, 2017. September 6, 2017. September 6, 2017. September 6, 2017. September 6, 2017. September 6, 2017. September 6, 2017. September 15, 2017. September 18, 2017. September 18, 2017. September 18, 2017. September 18, 2017. September 18, 2017. September 29, 2017. September 29, 2017. DEPARTMENT OF JUSTICE Drug Enforcement Administration Linda M. Shuck, D.O.; Decision and Order BILLING CODE 4410–09–P On July 25, 2017, the Assistant Administrator, Diversion Control Division, Drug Enforcement Administration, issued an Order to Show Cause to Linda M. Shuck (Registrant), of Dobson, North Carolina. The Show Cause Order proposed the revocation of Registrant’s Certificate of Registration, on the ground that she that Respondent violated state law by ‘‘[p]rescribing, dispensing, or administering legally controlled substances or any dependency-inducing medication without legitimate medical justification thereof or in other than a legal or legitimate manner.’’ See 82 FR at 39618 n.8 (2017); see also Mot. for Summ. Disp., Appendix B, at 22, 24 (Louisiana Board Order at 12, 14). For the same reasons as those cited by the former Acting Administrator, I find that the public interest necessitates that this Order be effective immediately. See also 21 CFR 1316.67. Dated: November 16, 2017. Demetra Ashley, Acting Assistant Administrator. [FR Doc. 2017–25284 Filed 11–21–17; 8:45 am] PO 00000 Frm 00087 Fmt 4703 Sfmt 4703 E:\FR\FM\22NON1.SGM 22NON1

Agencies

[Federal Register Volume 82, Number 224 (Wednesday, November 22, 2017)]
[Notices]
[Page 55639]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-25284]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Registrants listed below have applied for and been granted 
registration by the Drug Enforcement Administration as importers of 
various classes of schedule I or II controlled substances.

SUPPLEMENTARY INFORMATION: The companies listed below applied to be 
registered as importers of various basic classes of controlled 
substances. Information on previously published notices is listed in 
the table below. No comments or objections were submitted and no 
requests for hearing were submitted for these notices.

----------------------------------------------------------------------------------------------------------------
                 Company                             FR Docket                           Published
----------------------------------------------------------------------------------------------------------------
Almac Clinical Services Incorp (ACSI)...  82 FR 37114                     August 8, 2017.
Stepan Company..........................  82 FR 41054                     August 29, 2017.
Fresenius Kabi USA, LLC.................  82 FR 41053                     August 29, 2017.
Cambrex Charles City....................  82 FR 41055                     August 29, 2017.
Spex Certiprep Group, LLC...............  82 FR 42120                     September 6, 2017.
Akorn, Inc..............................  82 FR 42117                     September 6, 2017.
Fisher Clinical Services, Inc...........  82 FR 42121                     September 6, 2017.
Siegfried USA, LLC......................  82 FR 42117                     September 6, 2017.
Mylan Pharmaceuticals, Inc..............  82 FR 42120                     September 6, 2017.
KVK-Tech, Inc...........................  82 FR 42119                     September 6, 2017.
Cerilliant Corporation..................  82 FR 43404                     September 15, 2017.
Unither Manufacturing LLC...............  82 FR 43571                     September 18, 2017.
Mylan Pharmaceuticals, Inc..............  82 FR 43572                     September 18, 2017.
Catalent Centers, LLC...................  82 FR 43569                     September 18, 2017.
Specgx LLC..............................  82 FR 43571                     September 18, 2017.
Sharp Clinical Services, Inc............  82 FR 43572                     September 18, 2017.
Cody Laboratories, Inc..................  82 FR 45612                     September 29, 2017.
Bellwyck Clinical Services..............  82 FR 45613                     September 29, 2017.
----------------------------------------------------------------------------------------------------------------

    The Drug Enforcement Administration (DEA) has considered the 
factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the 
registration of the listed registrants to import the applicable basic 
classes of schedule I or II controlled substances is consistent with 
the public interest and with United States obligations under 
international treaties, conventions, or protocols in effect on May 1, 
1971. The DEA investigated each company's maintenance of effective 
controls against diversion by inspecting and testing each company's 
physical security systems, verifying each company's compliance with 
state and local laws, and reviewing each company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the DEA has granted a registration as 
an importer for schedule I or II controlled substances to the above 
listed persons.

    Dated: November 16, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017-25284 Filed 11-21-17; 8:45 am]
 BILLING CODE 4410-09-P